what firm is helping boston scientific with acquisitions
The acquisition of Rhythmia Medical will enhance Boston Scientificâs presence in the rapidly growing $2.5-billion market of electrophysiology mapping and ablation device treatments for irregular heartbeats. The deal will help the company compete more effectively with J&J and St. Jude Medical, which have products addressing this market.